Cinacalcet is associated with decreased serum FGF-23 and improved phosphorous homeostasis in patients with tumor-induced osteomalacia.

被引：0
|
作者：
Geller, JL
Cutler, C
Kelly, MH
Adams, JS
Collins, MT
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr, Div Endocrinol,Burns & Allen Res Inst, Los Angeles, CA USA
[2] NIDCR, Craniofacial & Skeletal Dis Branch, NIH, DHHS, Bethesda, MD USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2005年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S177 / S177
页数：1
相关论文
共 47 条
  • [1] FGF-23 protein is present in normal plasma and is increased in patients with tumor-induced osteomalacia.
    Yamazaki, Y
    Shibata, M
    Okazaki, R
    Takeuchi, Y
    Fujita, T
    Yamashita, T
    Fukumoto, S
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S159 - S159
  • [2] TUMOR-INDUCED OSTEOMALACIA CAUSED BY A FGF-23 PRODUCING MESENCHYMAL TUMOR
    Hu, Sophia
    Lubitz, Sara
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2014, 29 : S460 - S460
  • [3] FGF-23, FGF-7, sFRP-4, and MEPE expression in tumor induced osteomalacia.
    Habra, MA
    Huang, SE
    Cote, GJ
    Murphy, WA
    Katz, RL
    Gagel, RF
    Klein, MJ
    Hoff, AO
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S344 - S344
  • [4] TUMOR-INDUCED OSTEOMALACIA (TIO) WITH ELEVATED FGF-23 CAUSING HYPOPHOSPHATEMIA IN OVARIAN MALIGNANCY
    Paster, L.
    Mastroianni, F.
    Ross, D.
    Feldhamer, K.
    Wanchoo, R.
    Jhaveri, K. D.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (04) : A65 - A65
  • [5] Sensitivity of FGF23 measurements in tumor induced osteomalacia.
    Imel, EA
    Peacock, M
    Pitukcheewanont, P
    Heller, HJ
    Ward, LM
    Shulman, D
    Kassem, M
    Rackoff, P
    Zimering, M
    Dalkin, A
    Drobney, E
    Colussi, G
    Shaker, J
    Hoogendorn, EH
    Econs, MJ
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S178 - S178
  • [6] Elevated serum FGF23 protein associated with tumor-induced osteomalacia: A case report
    不详
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S95 - S95
  • [7] Tumor-Induced Osteomalacia: Increased Level of FGF-23 in a Patient with a Phosphaturic Mesenchymal Tumor at the Tibia Expressing Periostin
    Hautmann, Anke H.
    Schroeder, Josef
    Wild, Peter
    Hautmann, Matthias G.
    Huber, Elisabeth
    Hoffstetter, Patrick
    Fleck, Martin
    Girlich, Christiane
    [J]. CASE REPORTS IN ENDOCRINOLOGY, 2014, 2014
  • [8] Tumor-induced osteomalacia: increased level of FGF-23 in a patient with a mesenchymal giant cell tumor at the tibia expressing Periostin
    Hautmann, A. H.
    Schroeder, J.
    Wild, P.
    Hautmann, M.
    Hoffstetter, P.
    Girlich, C.
    Fleck, M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 156 - 157
  • [9] A Case of Tumor-Induced Osteomalacia (TIO) with Paradoxical Fibroblast Growth Factor 23 (FGF-23) Response After Surgical Excision
    Rahim, Shab E. Gul
    Epstein, David L.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 789 - 789
  • [10] Diagnostic Modalities for FGF23-Producing Tumors in Patients with Tumor-Induced Osteomalacia
    Fukumoto, Seiji
    [J]. ENDOCRINOLOGY AND METABOLISM, 2014, 29 (02) : 136 - 143
12345